Articles by Ankit Singhania

Based in India, Ankit is a financial content writer and stock market analyst. He has worked for almost a decade on several financial projects related to the stock market news, fundamental research and technical analysis for several websites. He obtained his Masters Degree In finance (MS – finance) from ICFAI. Currently, he serves as a financial consultant and technical analyst at Tradersinsights.com.

PRVB Stock Skyrockets As Investors Cheer Teplizumab’s Positive Results

Jun 10 Ankit Singhania

PRVB stock in on fire and skyrockets as much as 300% after Provention Bio Inc (NASDAQ:PRVB) announced positive outcomes from its trial of teplizumab, its lead candidate. PRVB stock Jumps Big New Jersey-based Provention Bio, ... [Read]

BKS Stock Soars 60% in 2 Days On Acquisition News

Jun 7 Ankit Singhania

BKS stock continues to move Friday after Elliott Management agreed to acquire Barnes & Noble Inc. (NYSE:BKS) for $476 million or $6.50 a share. Acquisition Details Iconic American bookstore Barnes & Noble has been in ... [Read]

CLDR Stock Slumps to a New Low As CEO Leaves Cloudera

Jun 6 Ankit Singhania

CLDR stock is showing severe selling pressure in Thursday’s trading session as Cloudera Inc (NYSE:CLDR) revealed Q1 results that missed analyst estimates, with revenue growth mainly driven by the Hortonworks acquisition. Additionally, the company announced ... [Read]

AMBA Stock Skyrockets: Investors Cheer a Surprise Profit

Jun 5 Ankit Singhania

Ambarella Inc (NASDAQ:AMBA) has released its Q1 2019 results in which the company reported profits that beat Wall Street consensus estimates, and as a result, AMBA stock gained 8% on Wednesday. Despite the macroeconomic risks ... [Read]

PTI Stock Jumps As EU Grants Orphan Drug Designation

Jun 4 Ankit Singhania

PTI stock is moving higher in Tuesday’s session following the news that Proteostasis Therapeutics Inc (NASDAQ:PTI) received orphan drug designation in the EU for PTI-428, its treatment for cystic fibrosis. Orphan Drug Designation Boston, Massachusetts-based ... [Read]

GME Stock in Focus Ahead of Q1 Earnings: GameStop Faltering

Jun 3 Ankit Singhania

GME stock is trading lower ahead of GameStop Corp’s (NYSE:GME) first-quarter results. GameStop Corp has had to deal with declining sales in the past year, which the retailer’s diversification strategy could not offset. However, that ... [Read]

ZUO Stock Tumbles As Zuora Trims Revenue Outlook

May 31 Ankit Singhania

ZUO stock is taking a hit on Friday after Zuora Inc (NYSE:ZUO) estimated lower than expected revenue for the year. California-based enterprise software company Zoura Inc, whose business is primarily based on subscription management software, ... [Read]

ONVO Stock Soars 90% on Collaboration News

May 30 Ankit Singhania

ONVO stock is getting a lot of attention on Thursday as Organovo Holdings Inc (NASDAQ:ONVO) announced a collaboration with MCRI and Leiden University Medical Center to develop stem cell-based bioprinted tissue treatments for kidney disease. The ... [Read]

CARA Stock Skyrockets 20% After Positive Results On KORSUVA

May 29 Ankit Singhania

CARA stock is on fire as Cara Therapeutics Inc (NASDAQ:CARA) reported positive topline results from a Phase 3 clinical trial, KALM-1, evaluating KORSUVA. Cara’s KORSUVA Successful As far as therapeutics companies are concerned, the completion ... [Read]

SDRL Stock Hits New Lows On Analyst Sell Note: Investors Flee

May 28 Ankit Singhania

SDRL stock continues to move lower in Tuesday’s session after Carnegie Investment Bank suggested selling Seadrill Ltd (NYSE:SDRL) shares amid mounting recovery worries. Carnegie Investment Cuts PT By 88% Bermuda incorporated deepwater drilling contractor Seadrill ... [Read]